Products
Online Inquiry
FO-32
Cat. No.:
OB0626WX-3670
Appearance:
Liquid
Purity:
≥98%
Identity:
Confirmed by NMR and HPLC.
Size:
Add to basket
Product Overview
Description:
FO-32 is a structurally optimized ionizable cationic lipid possessing an apparent pKa of 6.36, developed for the formulation of respiratory-targeted lipid nanoparticles. When delivered via intranasal or nebulized pathways, the lipid vehicle effectively navigates mucosal barriers to accumulate within the nasal epithelium and deep pulmonary tissues, driving successful intracellular internalization and high-level recombinase-mediated reporter expression in target organ models.
Synonyms:
di(dec-3-yn-1-yl) 5-(butylcarbamoyl)-5-(N-(3-(dimethylamino)propyl)-6-(heptadecan-9-yloxy)-6-oxohexanamido)nonanedioate; 3100308-37-7
CAS No.:
3100308-37-7
Compound CID:
175667457
Formula:
C62H111N3O8
Formula Weight:
1026.6
Specification
Solubility in Other Solvents:
Methyl acetate: ≥10 mg/mL
Storage:
Storage at -20°C.
Applications:
FO-32 supports research involving lipid nanoparticle formulation and functional lipid characterization. It can be used to investigate lipid composition, nanoparticle engineering strategies, and structure–function relationships associated with lipid-based delivery materials.
